Skip to main content
OpenTrials

Clinical trial condition

Advanced Tumors

Explore clinical trials studying Advanced Tumors. Study availability and eligibility vary by location and protocol.

16 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Advanced Tumors trial results

Active, not recruiting

Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

NCT06788938

Conditions
Advanced Tumors, DLL3-expressing Tumors, Neoplasms
Locations
  • UC Davis Comprehensive Cancer Center Davis, California, United States
  • UCI Health Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • UC San Diego Moores Cancer Center San Diego, California, United States
View Trial Details
Completed

Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours

NCT03697304

Conditions
Advanced Tumors, Metastatic Solid Tumors, Neoplasm Metastasis, +4 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Florida Cancer Specialists-Fort Myers-52980 Fort Myers, Florida, United States
  • Florida Cancer Specialists-Saint Petersburg-52979 St. Petersburg, Florida, United States
  • Florida Cancer Specialists-Sarasota-61670 Tallahassee, Florida, United States
View all 17 locations
View Trial Details

Related conditions